Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: Implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer

British Journal of Cancer

Volumn 92, Issue 8, 2005, Pages 1538-1544

  Koike, H ^a   Ito, K ^a   Takezawa, Y ^a   Oyama, T ^a   Yamanaka, H ^a   Suzuki, K ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diethylstilbestrol; IGFBP 6; Prostate cancer

Indexed keywords

ANDROGEN; COMPLEMENTARY DNA; DIETHYLSTILBESTROL; PROTEIN ANTIBODY; SOMATOMEDIN BINDING PROTEIN 6; TESTOSTERONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CASTRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; GENE EXPRESSION; HORMONE RESISTANCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN FUNCTION; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DIETHYLSTILBESTROL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION PROFILING; HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 18944378092     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602520     Document Type: Article

References (24)

1. Abramson FP, Miller Jr HC (1982) Bioavailability, distribution and pharmacokinetics of diethylstilbestrol produced from stilphostrol. J Ural 128: 1336-1339
2. Bach LA (1999) Insulin-like growth factor binding protein-6: the 'forgotten' binding protein. Horm Metab Res 31: 226-234
3. Bach LA, Hsieh S, Brown AL, Rechler MM (1994) Recombinant human insulin-like growth factor(IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Endocrinology 135: 2168-2176
4. Band PR, Banerjee TK, Patwardhan VC, Eid TC (1973) High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens. Can Med Assoc J 109: 697-699
5. Brehmer B, Marquardt H, Madsen PO (1972) Growth and hormonal response of cells derived from carcinoma and hyperplasia of the prostate in monolayer cell culture. A possible in vitro model for clinical chemotherapy. J Urol 108: 890-896
6. Colapinto V, Aberhart C (1961) Clinical trial of massive stilbestrol diphosphate therapy in advanced carcinoma of the prostate. Br J Urol 33: 171-177
7. Drivdahl RH, Loop SM, Andress DL, Ostenson RC (1995) IGF-binding proteins in human prostate tumor cells: expression and regulation by 1,25-dihydroxyvitamin D3. Prostate 26: 72-79
8. Droz JP, De Smedt E, Kattan J, Keuppens F, Khoury S, Mahler C, Denis L (1994) Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostate. Prostate 24: 62-66
9. Ferro MA, Gillatt D, Symes MO, Smith PJ (1989) High-dose intravenous estrogen therapy in advanced prostatic carcinoma. Use of serum prostate-specific antigen to monitor response. Urology 34: 134-138
10. Flocks RH, Marberger H, Begley BJ, Hans M, Prendergast LJ (1955) Prostatic carcinoma:treatment of advanced cases with intravenous diethylstilbestrol diphosphate. J Urol 74: 549-551
11. Gallicchio MA, Kneen M, Hall C, Scott AM, Bach LA (2001) Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo. Int J Cancer 94: 645-651
12. Grellier P, Berrebi D, Peuchmaur M, Babajko S (2002) The IGF system in neuroblastoma xenografts: focus on IGF-binding protein-6. J Endocrinol 172: 467-476
13. Hartley B, Deinum J, Wallin M (1985) Diethylstilbestrol induces metaphase arrest and inhibits microtubule assembly. Mutat Res 143: 231-235
14. Hasumi M, Suzuki K, Matsui H, Koike H, Ito K, Yamanaka H (2003) Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett 200: 187-195
15. Hawtrey CE, Welch Jr MJ, Schmidt JD, Gulp DA, Flocks RH (1974) Paraplegia and paraparesis due to prostate cancer. Use of intravenous diethylstilbestrol diphosphate. Urology 4: 431-434
16. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, Zapf J (1992) Characterization of recombinant human insulin-like growth factor(IGF)-binding proteins 4,5 and 6 produced in yeast. J Biol Chem 267: 12692-12699
17. Kimura G, Kasuya J, Giannini S, Honda Y, Mohan S, Kawachi MH, Akimoto M, Yamaguti Y (1996) Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int J Urol 3: 39-46
18. McEnery MW, Hullihen J, Pedersen PL (1989) F0 proton channel of rat liver mitochondria. Rapid purification of a functional complex and a study of its interaction with the unique probe diethylstilbestrol. J Biol Chem 264: 12029-12036
19. Paulson DF (1984) Carcinoma of the prostate: the therapeutic dilemma. Annu Rev Med 35: 341-372
20. Robertson CN, Roberson KM, Padilla GM, Brien ETO', Cook JM, Kim CS, Fine RL (1996) Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. JNCI 88: 908-917
21. Schulz P, Link TA, Chaudhuri L, Fittler F (1990) Role of the mitochondrial bcl-complex in the cytotoxic action of diethylstilbestrol- diphosphate toward prostatic carcinoma calls. Cancer Res 50: 5008-5012
22. Suzuki K, Koike H, Matsui H, Ono Y, Hasumi M, Nakazato H, Okugi H, Sekine Y, Oki K, Ito K, Yamamoto T, Fuksbori Y, Kurokawa K, Yamanaka H (2002) Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int J Cancer 99: 846-852
23. Takezawa Y, Nakata S, kobayashi M, kosaku N, Fukabori Y, Yamanaka H (2001) Moderate dose diethylstilbestrol diphosphate therapy in hormone refractory prostate cancer. Scand J Urol Nephrol 35: 283-287
24. Yokota E, Ichinosei K, Sato Y (1994) Microtubule disruption induced by estradiol in estrogen receptor-positive and -negative human breast cancer cell lines. Carcinogenesis 15: 1875-1879